Amdocs Limited (NASDAQ:DOX) Stock Position Increased by Meitav Investment House Ltd.

Meitav Investment House Ltd. raised its position in shares of Amdocs Limited (NASDAQ:DOXFree Report) by 2.7% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 13,400 shares of the technology company’s stock after purchasing an additional 350 shares during the period. Meitav Investment House Ltd.’s holdings in Amdocs were worth $1,309,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. JPMorgan Chase & Co. bought a new position in shares of Amdocs in the first quarter worth $7,002,000. Raymond James Financial Services Advisors Inc. raised its position in shares of Amdocs by 6.0% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 11,833 shares of the technology company’s stock worth $973,000 after buying an additional 665 shares in the last quarter. PNC Financial Services Group Inc. lifted its stake in shares of Amdocs by 40.5% in the 1st quarter. PNC Financial Services Group Inc. now owns 13,332 shares of the technology company’s stock worth $1,097,000 after acquiring an additional 3,840 shares during the period. Great West Life Assurance Co. Can increased its stake in shares of Amdocs by 3.2% during the first quarter. Great West Life Assurance Co. Can now owns 46,252 shares of the technology company’s stock valued at $4,041,000 after acquiring an additional 1,446 shares during the period. Finally, Yousif Capital Management LLC raised its holdings in Amdocs by 6.4% during the first quarter. Yousif Capital Management LLC now owns 6,770 shares of the technology company’s stock worth $557,000 after purchasing an additional 405 shares in the last quarter. 90.58% of the stock is owned by institutional investors and hedge funds.

Amdocs Trading Up 0.8 %

Shares of NASDAQ DOX opened at $82.24 on Friday. The business has a fifty day simple moving average of $83.01 and a 200-day simple moving average of $89.50. The company has a market cap of $9.94 billion, a price-to-earnings ratio of 18.36, a P/E/G ratio of 1.31 and a beta of 0.68. Amdocs Limited has a 12 month low of $78.38 and a 12 month high of $99.75. The company has a quick ratio of 1.50, a current ratio of 1.41 and a debt-to-equity ratio of 0.22.

Amdocs (NASDAQ:DOXGet Free Report) last released its quarterly earnings results on Monday, November 6th. The technology company reported $1.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.28 by $0.14. Amdocs had a net margin of 11.06% and a return on equity of 17.77%. The business had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.25 billion. During the same quarter in the previous year, the business earned $1.17 earnings per share. The firm’s revenue was up 6.6% compared to the same quarter last year. Sell-side analysts predict that Amdocs Limited will post 5.96 EPS for the current year.

Amdocs Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be issued a dividend of $0.435 per share. This represents a $1.74 annualized dividend and a dividend yield of 2.12%. The ex-dividend date of this dividend is Thursday, December 28th. Amdocs’s dividend payout ratio is currently 38.84%.

Wall Street Analysts Forecast Growth

DOX has been the subject of a number of research reports. Oppenheimer increased their price target on Amdocs from $99.00 to $109.00 and gave the company an “outperform” rating in a research note on Thursday, August 3rd. assumed coverage on shares of Amdocs in a research report on Thursday, October 5th. They issued a “buy” rating on the stock. One equities research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, Amdocs has an average rating of “Moderate Buy” and an average price target of $108.50.

View Our Latest Stock Analysis on DOX

Amdocs Company Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES21, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; the Commerce and Care suite for order capture, handling, and customer engagement; the Monetization suite for charging, billing, policy, and revenue management; Intelligent Networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; MarketONE, a cloud-native business ecosystem; Digital Brands Suite, a pre-integrated digital business suite for digital telecom brands and small-scale service providers; and eSIM Cloud for service providers.

See Also

Want to see what other hedge funds are holding DOX? Visit to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOXFree Report).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with's FREE daily email newsletter.